The Advanced Training Institute of the National Medical Products Administration is scheduled to hold a training course on the regulatory requirements and application practices for the research and registration of traditional Chinese medicine in Kunming, Yunnan in early July 2023.

Shandong Xinbo Pharmaceutical R&D Co., Ltd. was invited to participate in this grand event. On the morning of July 4th, Liu Baofeng, Vice General Manager of Shandong Xinbo, gave a speech on the theme of "Focus on Preclinical Safety Evaluation of Traditional Chinese Medicine". We sincerely invite colleagues in the industry to attend this conference and communicate with the guests.

Vice General Manager of Shandong Xinbo Pharmaceutical Research Co., Ltd

Engaged in the preclinical safety evaluation industry for 21 years

• Rich experience in preclinical safety evaluation of chemical drugs, biological drugs, and traditional Chinese medicine
• Executive Committee Member of the Chinese Pharmacology and Safety Research Branch of the Chinese Association of Traditional Chinese Medicine
• Member of the Drug Toxicology Professional Committee of Shandong Pharmacological Society
• Director of Shandong Society of Toxicology